Notably, studies have found mTOR to be hyperactive in both in vitro and in vivo AD models, partly by Aβ, since a reduction of Aβ in the 3xTg-AD mouse model showed a reverse in mTOR hyperactivity [53]. The gene discussed is MTOR; the disease is Alzheimer disease.